220 related articles for article (PubMed ID: 37394540)
1. Carcinoma of unknown primary (CUP): an update for histopathologists.
Beauchamp K; Moran B; O'Brien T; Brennan D; Crown J; Sheahan K; Cotter MB
Cancer Metastasis Rev; 2023 Dec; 42(4):1189-1200. PubMed ID: 37394540
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.
Oien KA; Dennis JL
Ann Oncol; 2012 Sep; 23 Suppl 10():x271-7. PubMed ID: 22987975
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic challenges of patients with carcinoma of unknown primary.
Rassy E; Pavlidis N
Expert Rev Anticancer Ther; 2020 Sep; 20(9):775-783. PubMed ID: 32779501
[TBL] [Abstract][Full Text] [Related]
4. Practical Applications in Immunohistochemistry: Carcinomas of Unknown Primary Site.
Kandalaft PL; Gown AM
Arch Pathol Lab Med; 2016 Jun; 140(6):508-23. PubMed ID: 26457625
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
6. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and therapeutic management of cancer of an unknown primary.
Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary.
El Rassy E; Khaled H; Pavlidis N
Eur J Cancer; 2018 Dec; 105():28-32. PubMed ID: 30388661
[TBL] [Abstract][Full Text] [Related]
9. Carcinomas of an unknown primary origin--diagnosis and treatment.
Massard C; Loriot Y; Fizazi K
Nat Rev Clin Oncol; 2011 Nov; 8(12):701-10. PubMed ID: 22048624
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.
Greco FA
Curr Treat Options Oncol; 2013 Dec; 14(4):634-42. PubMed ID: 23990214
[TBL] [Abstract][Full Text] [Related]
11. Cancers of unknown primary origin: current perspectives and future therapeutic strategies.
Stella GM; Senetta R; Cassenti A; Ronco M; Cassoni P
J Transl Med; 2012 Jan; 10():12. PubMed ID: 22272606
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
13. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
Alberti C
G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases.
Qi P; Sun Y; Liu X; Wu S; Wo Y; Xu Q; Wang Q; Hu X; Zhou X
Cancer Med; 2023 Jan; 12(2):1177-1188. PubMed ID: 35822433
[TBL] [Abstract][Full Text] [Related]
17. From Biology to Diagnosis and Treatment: The Ariadne's Thread in Cancer of Unknown Primary.
Mathew BG; Aliyuda F; Taiwo D; Adekeye K; Agada G; Sanchez E; Ghose A; Rassy E; Boussios S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982662
[TBL] [Abstract][Full Text] [Related]
18. 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary.
Losa F; Iglesias L; Pané M; Sanz J; Nieto B; Fusté V; de la Cruz-Merino L; Concha Á; Balañá C; Matías-Guiu X
Clin Transl Oncol; 2018 Nov; 20(11):1361-1372. PubMed ID: 29808414
[TBL] [Abstract][Full Text] [Related]
19. [Metastases of unknown origin--principles of diagnosis and treatment].
Petrović D; Muzikravić L; Jovanović D
Med Pregl; 2007; 60(1-2):29-36. PubMed ID: 17853708
[TBL] [Abstract][Full Text] [Related]
20. [Cancer of unknown primary-The new ESMO guidelines].
Bochtler T; Pouyiourou M; Krämer A
Radiologie (Heidelb); 2023 May; 63(5):329-335. PubMed ID: 36930265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
